Serda Therapeutics
1 known investors
SERDA therapeutics is developing a prescription enzyme-based product for therapeutic debridement, using a proteolytic enzyme to selectively digest and remove necrotic tissue and eschar from wounds. It targets burn injuries and chronic wounds such as open leg and diabetic foot ulcers.
Investors · 1
Frequently asked questions
- What does Serda Therapeutics do?
- SERDA therapeutics is developing a prescription enzyme-based product for therapeutic debridement, using a proteolytic enzyme to selectively digest and remove necrotic tissue and eschar from wounds. It targets burn injuries and chronic wounds such as open leg and diabetic foot ulcers.
- Who are Serda Therapeutics's investors?
- Serda Therapeutics's investors include NLC.